Insider Transactions in Q4 2020 at Altimmune, Inc. (ALT)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,025
-0.95%
|
$33,275
$11.3 P/Share
|
|
Dec 10
2020
|
Klaus Schafer Director |
BUY
Open market or private purchase
|
Direct |
2,000
+18.35%
|
$22,000
$11.99 P/Share
|
|
Dec 01
2020
|
Philip Hodges Director |
SELL
Open market or private sale
|
Indirect |
1,227
-100.0%
|
$15,951
$13.54 P/Share
|
|
Nov 30
2020
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,243
-0.7%
|
$26,916
$12.23 P/Share
|
|
Nov 30
2020
|
John Gill Director |
SELL
Open market or private sale
|
Direct |
8,425
-42.93%
|
$92,675
$11.92 P/Share
|
|
Nov 30
2020
|
Philip Hodges Director |
SELL
Open market or private sale
|
Direct |
2,500
-14.51%
|
$30,000
$12.0 P/Share
|
|
Nov 13
2020
|
David Drutz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60
+0.34%
|
$120
$2.4 P/Share
|
|
Nov 12
2020
|
Matthew Scott Harris Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,015
-49.67%
|
$40,150
$10.02 P/Share
|
|
Nov 12
2020
|
Wayne Pisano Director |
SELL
Open market or private sale
|
Direct |
10,352
-54.92%
|
$93,168
$9.9 P/Share
|
|
Nov 12
2020
|
Klaus Schafer Director |
SELL
Open market or private sale
|
Direct |
10,150
-59.53%
|
$91,350
$9.91 P/Share
|
|
Oct 30
2020
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,015
-0.63%
|
$22,165
$11.45 P/Share
|